A Study to Assess the Safety, Tolerability and Efficacy of ION775
Part of paid clinical trials in Lincoln, California.
- Sponsor
- Ionis Pharmaceuticals, Inc.
- Study ID
- NCT07604974
- Phase
- PHASE2
- Status
- Recruiting
Conditions
- Hypertriglyceridemia
- Severe Hypertriglyceridemia
Eligibility Criteria
- Sex
- ALL
- Age
- 18 Years - N/A
- Healthy Volunteers
- Not accepted
Interventions
- ION775 — DRUGION775 will be administered by SC injection.
Study Details
The main objective of this study is to evaluate the effect of ION775 on fasting triglyceride (TG) levels in participants with hypertriglyceridemia (HTG) and severe hypertriglyceridemia (sHTG).
Key Dates
- Start date
- May 31, 2026
- Status verified
- May 2026
- Primary completion
- Sep 30, 2027
- Completion
- Mar 31, 2028
Study Design
- Enrollment
- 72 participants (estimated)
- Allocation
- RANDOMIZED
- Intervention model
- PARALLEL
- Primary purpose
- TREATMENT
Arms
- Experimental: ION775: Cohot AParticipants will be randomized to receive ION775 by subcutaneous (SC) injection.
- Experimental: ION775: Cohot BParticipants will be randomized to receive ION775 by SC injection.
- Experimental: ION775: Cohot CParticipants will be randomized to receive ION775 by SC injection.
Primary Outcome Measure
Percent Change From Baseline in Fasting Triglyceride (TG) [ Time Frame: Baseline, Month 6 ]
Central Contacts
- Ionis Pharmaceuticals, Inc.1-844-828-3770
Locations (8)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| Ionis Investigative Site | Lincoln | California | 95648 | - |
| Ionis Investigative Site | Miami | Florida | 33184 | - |
| Ionis Investigative Site | Miramar | Florida | 33027 | - |
| Ionis Investigative Site | Flint | Michigan | 48504 | - |
| Ionis Investigative Site | Munroe Falls | Ohio | 44262 | - |
| Ionis Investigative Site | Little River | South Carolina | 29566 | - |
| Ionis Investigative Site | Lampasas | Texas | 76550 | - |
| Ionis Investigative Site | San Antonio | Texas | 78209 | - |
Find similar trials in Lincoln, CA
Related Studies
- Long-Term Safety and Efficacy of Plozasiran in Adults With HypertriglyceridemiaPHASE3 · Recruiting · Arrowhead Pharmaceuticals · Bakersfield, California
- Study of Plozasiran in Adults With Severe Hypertriglyceridemia at Risk of Acute PancreatitisPHASE3 · Recruiting · Arrowhead Pharmaceuticals · Los Angeles, California
- A Mechanistic Study of MAR001 in Adults With Elevated Triglycerides and Remnant CholesterolPHASE2 · Recruiting · Marea Therapeutics · Chula Vista, California
- A Study of Solbinsiran (LY3561774) in Participants With Severe HypertriglyceridemiaPHASE2 · Recruiting · Eli Lilly and Company · Phoenix, Arizona